A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

N-Nitroso-Furosemide - Request Quote

Picture of N-Nitroso-Furosemide

N-Nitroso-Furosemide

SZ CAT No:SZ-F032009
CAS No
NA
Mol.F.
C12H9ClN3O6S : Na
Mol.Wt.
358.7 : 23.0
Inv. Status
Under QC Approval
Rel. CAS No2708280-93-5 (free base)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

N-Nitroso-Furosemide is chemically Sodium 4-chloro-2-((furan-2-ylmethyl)(nitroso)amino)-5-sulfamoylbenzoate. N-Nitroso-Furosemide is supplied with detailed characterization data compliant with regulatory guideline. N-Nitroso-Furosemide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Furosemide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality N-Nitroso-Furosemide

Purchase N-Nitroso-Furosemide

N-Nitroso-Furosemide suppliers

N-Nitroso-Furosemide manufacturers

N-Nitroso-Furosemide price

Order N-Nitroso-Furosemide

Enquire N-Nitroso-Furosemide

N-Nitroso-Furosemide cost

N-Nitroso-Furosemide Supplier

N-Nitroso-Furosemide Distributor

N-Nitroso-Furosemide for Method Validation

Furosemide Reference Standard

N-Nitroso-Furosemide for ANDA Filing

N-Nitroso-Furosemide for Forced Degradation Studies

N-Nitroso-Furosemide Identification Standards

N-Nitroso-Furosemide for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,